Pulmonary Hypertension Clinical Trial
Official title:
Non-invasive Assessment of Pulmonary Artery Pressure and Right Ventricular Function in Patients With Pulmonary Hypertension
The assessment of pulmonary artery pressure (PAP) and parameters describing right ventricular
function stand in the focus of the diagnosis and clinical management of pulmonary
hypertension (PH). Right heart catheterization (RHC) is the gold standard method to measure
PAP and to provide hemodynamic information on right ventricular function. However, due to its
invasive nature, RHC is not optimal for screening and for close monitoring of the disease.
Therefore, the development of non-invasive methods providing reliable PAP measurements and
right ventricular functional parameters would be of major benefit.
Today, the most often used comprehensive non-invasive method for these purposes is
echocardiography. However, the method has limitations; in many cases PAP is significantly
under- or overestimated - especially in subjects with co-existing pulmonary diseases.
Regarding right ventricular function, although novel echocardiography parameters appear to be
promising, they have not yet been evaluated in all forms of PH.
Another emerging non-invasive method is cardiac magnetic resonance imaging (MRI). MRI is
considered to be as gold standard for the non-invasive assessment of right ventricular
function. In addition, our group showed that with a special approach ("vortex method"), MRI
enables the determination of PAP with physiologic accuracy, but the method has not yet been
validated systematically in different forms of PH.
All patients undergoing right heart catheterization in our clinic are candidates for the
study. Excluded will be patients not eligible for MRI or declining to take part in the study.
MRI and Echocardiography will be performed within two weeks of the RHC.
Hypothesis:
1. MRI is superior to echocardiography to non-invasively determine mean PAP in a broad
collective of patients with PH of diverse ethology.
2. MRI derived right ventricular functional parameters correlate better to invasive
measurements and to established prognostic parameters than echocardiography derived
right ventricular functional parameters.
3. Novel right ventricular tissue Doppler parameters add substantially to "classical"
echocardiography parameters to describe right ventricular function.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01950585 -
Hydroxyurea in Pulmonary Arterial Hypertension
|
Early Phase 1 | |
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Completed |
NCT03649932 -
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
|
Phase 1 | |
Recruiting |
NCT04554160 -
Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring
|
||
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT01894035 -
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
|
||
Not yet recruiting |
NCT04083729 -
Persistent Pulmonary Hypertension After Percutaneous Mitral Commissurotomy
|
N/A | |
Terminated |
NCT02243111 -
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
|
N/A | |
Terminated |
NCT02246348 -
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
|
N/A | |
Completed |
NCT02821156 -
Study on the Use of Inhaled NO (iNO)
|
N/A | |
Completed |
NCT02216279 -
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
|
Phase 2 | |
Recruiting |
NCT01913847 -
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
|
Phase 3 | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT06240871 -
Contrast Enhanced PA Pressure Measurements
|
||
Completed |
NCT02377934 -
Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study
|
||
Recruiting |
NCT01091012 -
Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
|
Phase 3 | |
Completed |
NCT01463514 -
Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension
|
N/A | |
Completed |
NCT02275793 -
The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
|
||
Completed |
NCT01484899 -
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
|
N/A | |
Completed |
NCT00739375 -
The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.
|
Phase 1 |